There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

The number of adults living with diabetes worldwide has surpassed 800 million, more than quadrupling since 1990, according to new data released in The Lancet on World Diabetes Day.

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...